Gordon Li, MD

Neurosurgeon

Assistant Professor of Neurosurgery and, by courtesy, of Neurology at the Stanford University Medical Center

Brain Tumor Center

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Neurocritical Care Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 866-742-4811
Learn More About the Clinic Getting Here Make An Appointment

Brain Tumor Center at the Advanced Medicine Center, Clinic D

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: University of California Davis (2004) CA

Residency: Stanford University (2011) CA

Internship: Stanford University (2005) CA

Bachelor of Science, Brown University, Neuroscience (1999)

Honors & Awards

Stanford Spectrum-Medtech Translational Grant, Stanford Spectrum (2014)

Stanford Cancer Institute Bioscience Screening Award, Stanford Cancer Institute (2014)

K08 Mentored Research Grant: PI, NIH-KNS085333A (2013-2018)

Disease Team Therapy Development Planning Award (Planning Investigator), CIRM (DR2-05373) (2011-2012)

Center for Brain and Behavior Awards in Pediatric Neurosciences (co-investigator), Lucile Packard Children's Hospital (2009-2011)

Grand Opportunity Grant (co-investigator), NIH (RC2CA148491-01) (2009-2011)

Ruth L. Kirschstein National Research Service Award (PI), NIH-NCI (1F32CA132329-01) (2008-2010)

SANS Challenge Finalist, Congress of Neurological Surgeons (2008)

Junior AOA, University of California, Davis (2002)

Ernest Gold Award, University of California, Davis (2001)

Predoctoral Research Award, University of California, Davis (2001)

Plummer Linzy Scholarship, University of California, Davis (2000)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III
Emlet, D. R., Gupta, P., Holgado-Madruga, M., Del Vecchio, C. A., Mitra, S. S., & Wong, A. J. (2014). Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III. CANCER RESEARCH, 74(4), 1238-1249.

Current Vaccine Trials in Glioblastoma: A Review
Xu, Lw., Chow, K. K., Lim, M., & Li, G. (2014). Current Vaccine Trials in Glioblastoma: A Review. JOURNAL OF IMMUNOLOGY RESEARCH.

Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient.
Medress, Z. A., Xu, L. W., Ziskin, J. L., Lefterova, M., Vogel, H., & Li, G. (2014). Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient. Clinical neuropathology.

The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy.
Patel, M. A., Kim, J. E., Ruzevick, J., Li, G., & Lim, M. (2014). The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy. Cancers, 6(4), 1953-1985.

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Nitta, R. T., Gholamin, S., Feroze, A. H., Agarwal, M., Cheshier, S. H., & Li, G. (2014). Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway. Oncogene.

The Combined Subtemporal-Transfacial Approach for the Resection of Juvenile Nasopharyngeal Angiofibromas with Intracranial Extension.
Kumar, A. R., Nayak, J. V., Janisiewicz, A. M., Li, G., & Oghalai, J. S. (2014). The Combined Subtemporal-Transfacial Approach for the Resection of Juvenile Nasopharyngeal Angiofibromas with Intracranial Extension. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases
Atalar, B., Modlin, L. A., Choi, C. Yh., Adler, J. R., Gibbs, I. C., & Soltys, S. G. (2013). Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(4), 713-718.

Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma
Chaichana, K. L., Pendleton, C., Chambless, L., Camara-Quintana, J., Nathan, J. K., & Quinones-Hinojos, A. (2013). Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. JOURNAL OF CLINICAL NEUROSCIENCE, 20(10), 1422-1426.

The invasive nature of glioblastoma.
Nitta, R. T., & Li, G. (2013). The invasive nature of glioblastoma. World neurosurgery, 80(3-4), 279-280.

The incidence and significance of multiple lesions in glioblastoma
Thomas, R. P., Xu, L. W., Lober, R. M., Li, G., & Nagpal, S. (2013). The incidence and significance of multiple lesions in glioblastoma. JOURNAL OF NEURO-ONCOLOGY, 112(1), 91-97.

Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.
Agarwal, M., Nitta, R. T., & Li, G. (2013). Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells. Journal of molecular and genetic medicine : an international journal of biomedical research, 8(1).

Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions.
Sherman, J. H., Smith, Z. A., Cho, J. M., Lim, M., Colen, C. B., & Yang, I. (2013). Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions. Surgical neurology international, 4, 35-?.

The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage
Lim, M., Bower, R. S., Wang, Y., Sims, L., Bower, M. R., & Guccione, S. (2012). The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. NEUROSURGICAL REVIEW, 35(3), 413-419.

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Li, G., Mitra, S. S., Monje, M., Henrich, K. N., Bangs, C. D., & Wong, A. J. (2012). Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas. JOURNAL OF NEURO-ONCOLOGY, 108(3), 395-402.

Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy.
Abrams, J., Li, G., Mindea, S. A., Haynes, C. M., & Cheng, I. (2012). Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy. European spine journal , 21, S436-40.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., & Weissman, I. L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6662-6667.

Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT
Camara-Quintana, J. Q., Nitta, R. T., & Li, G. (2012). Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT. NEUROSURGERY CLINICS OF NORTH AMERICA, 23(2), 237-?.

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas
Del Vecchio, C. A., Li, G., & Wong, A. J. (2012). Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. EXPERT REVIEW OF VACCINES, 11(2), 133-144.

Perspectives on key articles in neurosurgery.
Lim, M., Sherman, J. H., Wang, V. Y., Smith, Z. A., Cho, J. M., & Yang, I. (2012). Perspectives on key articles in neurosurgery. Surgical neurology international, 3, 58-?.

RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS
Guss, Z. D., Batra, S., Limb, C. J., Li, G., Sughrue, M. E., & Lim, M. (2011). RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E497-E502.

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., & Beachy, P. A. (2011). Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(11), 4453-4458.

Neurosurgery concepts.
Yang, I., Cho, J. M., Colen, C. B., Li, G., Lim, M., & Wang, V. Y. (2011). Neurosurgery concepts. Surgical neurology international, 2, 173-?.

Development of an EGFRvIII specific recombinant antibody
Gupta, P., Han, S.-Y., Holgado-Madruga, M., Mitra, S. S., Li, G., & Wong, A. J. (2010). Development of an EGFRvIII specific recombinant antibody. BMC BIOTECHNOLOGY, 10.

Pineal Parenchymal Tumor of Intermediate Differentiation: Clinicopathological Report and Analysis of Epidermal Growth Factor Receptor Variant III Expression
Li, G., Mitra, S., Karamchandani, J., Edwards, M. Sb., & Wong, A. J. (2010). Pineal Parenchymal Tumor of Intermediate Differentiation: Clinicopathological Report and Analysis of Epidermal Growth Factor Receptor Variant III Expression. NEUROSURGERY, 66(5), 963-968.

Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas
Mitra, S., Li, G., & Harsh, G. R. (2010). Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 67-?.

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas
Li, G., Mitra, S., & Wong, A. J. (2010). The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 87-?.

Radiosurgery for glomus jugulare: history and recent progress
Guss, Z. D., Batra, S., Li, G., Chang, S. D., Parsa, A. T., & Lim, M. (2009). Radiosurgery for glomus jugulare: history and recent progress. NEUROSURGICAL FOCUS, 27(6).

CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA
Hara, W., Tran, P., Li, G., Su, Z., Puataweepong, P., & Gibbs, I. C. (2009). CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA. NEUROSURGERY, 64(2), A26-A32.

Perioperative management of ventriculoperitoneal shunts during abdominal surgery
Li, G., & Dutta, S. (2008). Perioperative management of ventriculoperitoneal shunts during abdominal surgery. SURGICAL NEUROLOGY, 70(5), 492-497.

EGF receptor variant III as a target antigen for tumor immunotherapy
Li, G., & Wong, A. J. (2008). EGF receptor variant III as a target antigen for tumor immunotherapy. EXPERT REVIEW OF VACCINES, 7(7), 977-985.

Effects of age and Comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients
Li, G., Patil, C. G., Lad, S. P., Ho, C., Tian, W., & Boakye, M. (2008). Effects of age and Comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients. SPINE, 33(11), 1250-1255.

Intracranial hypotension from intrathecal baclofen pump insertion
Lad, S. P., Li, G., Lin, S.-C., & Henderson, J. M. (2008). Intracranial hypotension from intrathecal baclofen pump insertion. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 86(2), 75-79.

CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain.
Patil, C. G., Veeravagu, A., Bower, R. S., Li, G., Chang, S. D., & Adler, J. R. (2007). CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain. Neurosurgical focus, 23(6), E9-?.

Irradiation of glomus jugulare tumors: a historical perspective.
Li, G., Chang, S., Adler, J. R., & Lim, M. (2007). Irradiation of glomus jugulare tumors: a historical perspective. Neurosurgical focus, 23(6), E13-?.

CyberKnife rhizotomy for facetogenic back pain: a pilot study.
Li, G., Patil, C., Adler, J. R., Lad, S. P., Soltys, S. G., & Boakye, M. (2007). CyberKnife rhizotomy for facetogenic back pain: a pilot study. Neurosurgical focus, 23(6), E2-?.

Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report.
Li, G., Jayaraman, M. V., Lad, S. P., Adler, J., Do, H., & Steinberg, G. K. (2006). Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 15(5), 228-231.

Cerebral perfusion imaging in vasospasm.
Lad, S. P., Guzman, R., Kelly, M. E., Li, G., Lim, M., & Steinberg, G. K. (2006). Cerebral perfusion imaging in vasospasm. Neurosurgical focus, 21(3), E7-?.

Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus
Li, G., Siddiqui, J., Hendry, M., Akiyama, J., Edmondson, J., & Hawgood, S. (2002). Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 26(3), 277-282.

GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice
Hawgood, S., Akiyama, J., Brown, C., Allen, L., Li, G., & Poulain, F. R. (2001). GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 280(6), L1148-L1156.